Apr. 4, 2014, 1:12 PM
- The selloff accelerates, with the Nasdaq 100 (QQQ) and Russell 2000 (IWM) each now lower by 2.3%. Little-changed earlier, selling comes to the S&P 500 (SPY -0.7%) and DJIA (DIA -0.4%).
- What's working? Emerging markets for one. Another area of green is the utility sector (XLU +0.9%). Healthcare (XLV -0.8%) would usually get a bid on these days, but it's being dragged down by the continuing liquidation of the biotechs. There are also some pockets of green in basic materials (XLB -0.7%).
- Utility ETFs: XLU, IDU, VPU, NLR, GRID, JXI, NUCL, DBU, IPU, RYU, UPW, PUI, FUTY, FXU, SDP, PSCU, AXUT, UTLT
- Healthcare ETFs: IYH, XLV, VHT, PJP, XPH, CURE, FXH, IHE, RXL, IRY, IXJ, PPH, IHI, IHF, FHLC, XHS, PSCH, RYH, XHE, PTH, DRGS, AXHE, RXD
- Basic Materials ETFs: XLB, VAW, UYM, IYM, IGE, SMN, MATL, FXZ, PYZ, FMAT, RTM, SBM, PSCM
Jun. 27, 2012, 3:05 PM
Have a hankering to play the Obamacare ruling? It's risky, but if you must, here are a couple non-levered long-only ETF's ideas that traders are currently focused on: The Health Care Select Sector SPDR (XLV +1.1%) and the iShares Dow Jones U.S. Medical Devices Index Fund (IHI +1.6%). For the aggressive type, there are levered ETF's like: ProShares Ultra Health Care ETF (RXL +2.4%), or the Direxion Daily Healthcare Bull 3X Shares (CURE +4.5%). The tools are out there, how you use them is all up to you.| Jun. 27, 2012, 3:05 PM
Jun. 17, 2011, 3:46 PM
GenMark Diagnostics (GNMK +42%) soars on heavy volume after pricing its 7.07M share secondary offering at $4.25, slightly below Thursday's close. The deal was heavily over-subscribed and removes an overhang that has been pressuring the stock for the past week.| Jun. 17, 2011, 3:46 PM
See more details on sponsor's website